Immune reconstitution and treatment response in multiple sclerosis following alemtuzumab.
From the Department of Neurology (N.P.R.), Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales; and the Institute of Clinical Neurosciences (N.J.S.), University of Bristol, Frenchay Hospital, UK. robertsonnp@cf.ac.uk.
Neil P
NP
Robertson
From the Department of Neurology (N.P.R.), Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales; and the Institute of Clinical Neurosciences (N.J.S.), University of Bristol, Frenchay Hospital, UK.
Neil J
NJ
Scolding
D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology*; D008297:Male; D009103:Multiple Sclerosis / Q000473:pathology*; D013601:T-Lymphocytes / Q000187:drug effects*
D007155:Immunologic Factors